The Black Hole: CAR T Cell Therapy in AML

SIMPLE SUMMARY: Unlike B cell malignancies, the progress on generating an adoptive T cell therapy for relapsed/refractory acute myeloid leukemia (AML) remains insufficient. This review focuses on the main challenges in the field and novel strategies to overcome them. ABSTRACT: Despite exhaustive stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Atilla, Erden, Benabdellah, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216020/
https://www.ncbi.nlm.nih.gov/pubmed/37345050
http://dx.doi.org/10.3390/cancers15102713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216020/
https://www.ncbi.nlm.nih.gov/pubmed/37345050
http://dx.doi.org/10.3390/cancers15102713

Ejemplares similares